Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)
10.25
0.00 (0.00%)
USD |
NASDAQ |
Feb 22, 16:00
Gracell Biotechnologies Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| February 22, 2024 | 763.31M |
| February 21, 2024 | 763.31M |
| February 20, 2024 | 762.83M |
| February 16, 2024 | 752.76M |
| February 15, 2024 | 755.63M |
| February 14, 2024 | 765.23M |
| February 13, 2024 | 771.94M |
| February 12, 2024 | 764.27M |
| February 09, 2024 | 772.90M |
| February 08, 2024 | 761.39M |
| February 07, 2024 | 761.39M |
| February 06, 2024 | 762.35M |
| February 05, 2024 | 759.47M |
| February 02, 2024 | 759.47M |
| February 01, 2024 | 761.39M |
| January 31, 2024 | 760.43M |
| January 30, 2024 | 754.67M |
| January 29, 2024 | 756.59M |
| January 26, 2024 | 745.08M |
| January 25, 2024 | 745.08M |
| January 24, 2024 | 747.00M |
| January 23, 2024 | 747.96M |
| January 22, 2024 | 741.24M |
| January 19, 2024 | 738.37M |
| January 18, 2024 | 739.33M |
| Date | Value |
|---|---|
| January 17, 2024 | 741.24M |
| January 16, 2024 | 740.28M |
| January 12, 2024 | 739.33M |
| January 11, 2024 | 743.16M |
| January 10, 2024 | 743.16M |
| January 09, 2024 | 744.12M |
| January 08, 2024 | 740.28M |
| January 05, 2024 | 742.20M |
| January 04, 2024 | 748.92M |
| January 03, 2024 | 745.08M |
| January 02, 2024 | 748.92M |
| December 29, 2023 | 743.16M |
| December 28, 2023 | 732.61M |
| December 27, 2023 | 731.65M |
| December 26, 2023 | 731.65M |
| December 22, 2023 | 373.85M |
| December 21, 2023 | 393.99M |
| December 20, 2023 | 360.42M |
| December 19, 2023 | 343.15M |
| December 18, 2023 | 322.05M |
| December 15, 2023 | 323.01M |
| December 14, 2023 | 302.86M |
| December 13, 2023 | 289.43M |
| December 12, 2023 | 299.02M |
| December 11, 2023 | 247.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-144.54M
Minimum
Mar 14 2022
2.117B
Maximum
Feb 05 2021
289.69M
Average
88.94M
Median
Oct 27 2023
Enterprise Value Benchmarks
| RayzeBio inc (DELISTED) | 3.204B |
| Zai Lab Ltd | 792.79M |
| WuXi Biologics (Cayman) Inc | 6.593B |
| Axonics Inc | 3.069B |
| I-MAB | -172.81M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.345M |
| Total Expenses (Quarterly) | 16.83M |
| EPS Diluted (Quarterly) | -0.1106 |